Special Issue "Molecular Modification in Designing Next Generation Drug Delivery Systems"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 6038
Interests: functionalization of plasma proteins for pharmaceutical applications
Special Issues, Collections and Topics in MDPI journals
Absorption improvement, site-specific targeting, and controlled release are the three main goals of drug delivery. Drug delivery systems are engineered to accomplish the treatment outcomes of comfort, compliance, and accuracy in therapy. The molecular modification of drugs is a common drug development approach, but this frequently changes the specificity and affinities of ligand–receptor binding. Furthermore, controlled release for therapy precision could only be achieved through a rigorous drug delivery system architectural design. The development of next-generation drug delivery systems incorporating various technologies, such as analytical and synthetic sciences, DNA recombination and genetic mutation, artificial intelligence, and artificial organ substitutes such as artificial blood, should lead the current one-size-fits-all treatment modality to a much higher precision level of bioresponsivity, whereby a patient may potentially live a life similar to an average healthy person. Articles exhibiting molecular modifications to biomaterials and other drug-carrying and targeting shuttles such as liposomes are sought for this Special Issue. Submissions of articles that elaborate on the use of artificial intelligence, smart technologies, and other cutting-edge technologies that lead to the next generation of drug delivery systems to realise the ultimate objective of precision medicines are particularly encouraged.
Dr. Victor Tuan Giam Chuang
Dr. Yu Ishima
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- absorption enhancement
- artificial substitutes
- controlled release
- drug delivery systems
- genetic and chemical modifications
- medical devices
- precision medicines
- proteins, peptides, and oligonucleotides
- routes of administration
- smart technology